Advances in Human Mass Balance Studies: An IQ Consortium Perspective on Current Practices and Emerging Trends.
Saved in:
| Title: | Advances in Human Mass Balance Studies: An IQ Consortium Perspective on Current Practices and Emerging Trends. |
|---|---|
| Authors: | Boer J; Incyte Corporation, 1801 Augustine Cut-Off, Wilmington, Delaware, USA., Cannady E; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, USA., Cuyckens F; Johnson & Johnson, Turnhoutseweg, 30, Beerse, Belgium., Glaenzel U; PK Sciences, Novartis Pharma AG, Fabrikstrasse 14, WSJ-153 1.02, Basel, 4056, Switzerland., Granvil C; Work supported at Gilead Sciences, Foster City, California, USA., Huth F; PK Sciences, Novartis Pharma AG, 4056, Basel, Switzerland., James AD; PK Sciences, Novartis Pharma AG, Fabrikstrasse 14, WSJ-153 1.02, Basel, 4056, Switzerland., Li W; Work Supported at Bristol-Myers Squibb, Princeton, New Jersey, USA., Veau C; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany., Young G; GlaxoSmithKline Research & Development Ltd., David Jack Centre, Ware, UK., Yue Q; Work supported at Gilead Sciences, Foster City, California, USA., Walker GS; Pfizer, Groton, Connecticut, USA., Argikar UA; Gates Medical Research Institute, Cambridge, Massachusetts, USA., Bauman JN; Pfizer, Groton, Connecticut, USA., Cantalloube C; Sanofi, Vitry sur Seine, France., Chen YL; Sumitomo Pharma America, Marlborough, Massachusetts, USA., Kang P; Vertex Pharmaceuticals, San Diego, California, USA., Moliner P; Sanofi, Montpellier, France., Pedersen ML; Drug Metabolism and Pharmacokinetics, Early Research and Development, Cardiovascular, Renal and Metabolism, Biopharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Piel I; Bayer AG, Wuppertal, Germany., Schadt S; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland., Schieferstein H; The Healthcare Business of Merck KGaA, Darmstadt, Germany., Suchomel J; 1 DNA Way, MS 412a, DMPK, Genentech, Inc., South San Francisco, California, USA., Wang S; 1 DNA Way, MS 412a, DMPK, Genentech, Inc., South San Francisco, California, USA., Khojasteh SC; 1 DNA Way, MS 412a, DMPK, Genentech, Inc., South San Francisco, California, USA. |
| Source: | Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2026 Jul; Vol. 120 (1), pp. 43-54. Date of Electronic Publication: 2026 Mar 20. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535 (Electronic) Linking ISSN: 00099236 NLM ISO Abbreviation: Clin Pharmacol Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41860591 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Advances in Human Mass Balance Studies: An IQ Consortium Perspective on Current Practices and Emerging Trends. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Boer+J%22">Boer J</searchLink>; Incyte Corporation, 1801 Augustine Cut-Off, Wilmington, Delaware, USA.<br /><searchLink fieldCode="AU" term="%22Cannady+E%22">Cannady E</searchLink>; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, USA.<br /><searchLink fieldCode="AU" term="%22Cuyckens+F%22">Cuyckens F</searchLink>; Johnson & Johnson, Turnhoutseweg, 30, Beerse, Belgium.<br /><searchLink fieldCode="AU" term="%22Glaenzel+U%22">Glaenzel U</searchLink>; PK Sciences, Novartis Pharma AG, Fabrikstrasse 14, WSJ-153 1.02, Basel, 4056, Switzerland.<br /><searchLink fieldCode="AU" term="%22Granvil+C%22">Granvil C</searchLink>; Work supported at Gilead Sciences, Foster City, California, USA.<br /><searchLink fieldCode="AU" term="%22Huth+F%22">Huth F</searchLink>; PK Sciences, Novartis Pharma AG, 4056, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22James+AD%22">James AD</searchLink>; PK Sciences, Novartis Pharma AG, Fabrikstrasse 14, WSJ-153 1.02, Basel, 4056, Switzerland.<br /><searchLink fieldCode="AU" term="%22Li+W%22">Li W</searchLink>; Work Supported at Bristol-Myers Squibb, Princeton, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Veau+C%22">Veau C</searchLink>; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany.<br /><searchLink fieldCode="AU" term="%22Young+G%22">Young G</searchLink>; GlaxoSmithKline Research & Development Ltd., David Jack Centre, Ware, UK.<br /><searchLink fieldCode="AU" term="%22Yue+Q%22">Yue Q</searchLink>; Work supported at Gilead Sciences, Foster City, California, USA.<br /><searchLink fieldCode="AU" term="%22Walker+GS%22">Walker GS</searchLink>; Pfizer, Groton, Connecticut, USA.<br /><searchLink fieldCode="AU" term="%22Argikar+UA%22">Argikar UA</searchLink>; Gates Medical Research Institute, Cambridge, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Bauman+JN%22">Bauman JN</searchLink>; Pfizer, Groton, Connecticut, USA.<br /><searchLink fieldCode="AU" term="%22Cantalloube+C%22">Cantalloube C</searchLink>; Sanofi, Vitry sur Seine, France.<br /><searchLink fieldCode="AU" term="%22Chen+YL%22">Chen YL</searchLink>; Sumitomo Pharma America, Marlborough, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Kang+P%22">Kang P</searchLink>; Vertex Pharmaceuticals, San Diego, California, USA.<br /><searchLink fieldCode="AU" term="%22Moliner+P%22">Moliner P</searchLink>; Sanofi, Montpellier, France.<br /><searchLink fieldCode="AU" term="%22Pedersen+ML%22">Pedersen ML</searchLink>; Drug Metabolism and Pharmacokinetics, Early Research and Development, Cardiovascular, Renal and Metabolism, Biopharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.<br /><searchLink fieldCode="AU" term="%22Piel+I%22">Piel I</searchLink>; Bayer AG, Wuppertal, Germany.<br /><searchLink fieldCode="AU" term="%22Schadt+S%22">Schadt S</searchLink>; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Schieferstein+H%22">Schieferstein H</searchLink>; The Healthcare Business of Merck KGaA, Darmstadt, Germany.<br /><searchLink fieldCode="AU" term="%22Suchomel+J%22">Suchomel J</searchLink>; 1 DNA Way, MS 412a, DMPK, Genentech, Inc., South San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Wang+S%22">Wang S</searchLink>; 1 DNA Way, MS 412a, DMPK, Genentech, Inc., South San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Khojasteh+SC%22">Khojasteh SC</searchLink>; 1 DNA Way, MS 412a, DMPK, Genentech, Inc., South San Francisco, California, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220372741%22">Clinical pharmacology and therapeutics</searchLink> [Clin Pharmacol Ther] 2026 Jul; Vol. 120 (1), pp. 43-54. <i>Date of Electronic Publication: </i>2026 Mar 20. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Review – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0372741 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1532-6535 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200099236%22">00099236 </searchLink><i>NLM ISO Abbreviation: </i>Clin Pharmacol Ther <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41860591 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/cpt.70257 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 43 Titles: – TitleFull: Advances in Human Mass Balance Studies: An IQ Consortium Perspective on Current Practices and Emerging Trends. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Boer J – PersonEntity: Name: NameFull: Cannady E – PersonEntity: Name: NameFull: Cuyckens F – PersonEntity: Name: NameFull: Glaenzel U – PersonEntity: Name: NameFull: Granvil C – PersonEntity: Name: NameFull: Huth F – PersonEntity: Name: NameFull: James AD – PersonEntity: Name: NameFull: Li W – PersonEntity: Name: NameFull: Veau C – PersonEntity: Name: NameFull: Young G – PersonEntity: Name: NameFull: Yue Q – PersonEntity: Name: NameFull: Walker GS – PersonEntity: Name: NameFull: Argikar UA – PersonEntity: Name: NameFull: Bauman JN – PersonEntity: Name: NameFull: Cantalloube C – PersonEntity: Name: NameFull: Chen YL – PersonEntity: Name: NameFull: Kang P – PersonEntity: Name: NameFull: Moliner P – PersonEntity: Name: NameFull: Pedersen ML – PersonEntity: Name: NameFull: Piel I – PersonEntity: Name: NameFull: Schadt S – PersonEntity: Name: NameFull: Schieferstein H – PersonEntity: Name: NameFull: Suchomel J – PersonEntity: Name: NameFull: Wang S – PersonEntity: Name: NameFull: Khojasteh SC IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 07 Text: 2026 Jul Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1532-6535 Numbering: – Type: volume Value: 120 – Type: issue Value: 1 Titles: – TitleFull: Clinical pharmacology and therapeutics Type: main |
| ResultId | 1 |